SMAD3 expression levels in breast cancers harboring variants (BC-VAR; n = 3) were significantly higher compared to CO-VAR (n = 11; P = 0.038) and CO-REF (n = 12; P = 0.035) (Figure 1a). This evidence concerns the gene SMAD3 and breast carcinoma.